drugset / Trial / NCT02919995
A Study of RPL554 in Patients With Cystic Fibrosis
RandomizedCrossoverTriple-blindTreatment
Summary
This study evaluates two doses of RPL554 and placebo in adult patients with cystic fibrosis. All patients receive all three treatments in a randomised sequence.
Timeline
- Start
- 2017-02-08
- Primary completion
- 2017-11-03
- Completion
- 2017-11-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ensifentrine | Unknown | 1.5 mg | Inhaled |
| Subject | Ensifentrine | Unknown | 6 mg | Inhaled |